Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application.

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

2013 ACCF/AHA Guideline for the Management of Heart Failure

Heart Failure / CRT
HRS Endorsed / Affirmed

June 5, 2013—A report of the ACC/AHA Task Force on Practice Guidelines, developed in collaboration with the American College of Chest Physicians, the Heart Rhythm Society, and the International Society for Heart and Lung Transplantation, and endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, this guideline covers multiple management issues for the adult patient with heart failure. 

2013 Recommendations for Advanced Fellowship Training in Clinical Pediatric and Congenital Electrophysiology: A Report from the Training and Credentialing Committee of the Pediatric and Congenital Electrophysiology Society


April 30, 2013—The report expands upon guidelines published in 2005 and a supplemental consensus statement issued by the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) in 2008. The report provides an overview of training, didactic curriculum and research experience, clinical experience, and credentialing/certification.

 This document was reaffirmed on November 28, 2018, and will be formally assessed by November 2023.

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

Device Therapy
Heart Failure / CRT

March 7, 2013—This document was developed by the American College of Cardiology Foundation (ACCF) and the Heart Rhythm Society (HRS) along with key specialty societies. The document provides assessed levels of appropriateness for implanting ICDs and CRTs in 369 real-life case scenarios, with the goal of enhancing physician and patient decision making and improving care and health outcomes.

2012 EHRA/HRS Expert Consensus Statement on Cardiac Resynchronization Therapy in Heart Failure: Implant and Follow-up Recommendations and Management

Heart Failure / CRT

September 1, 2012The expert consensus statement provides recommendations for the practical management of cardiac resynchronization therapy (CRT) patients before, during, and after the implantation procedure. The statement does not discuss clinical indications for CRT therapy as these are covered by other guidelines statements.

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Device Therapy

September 10, 2012—The statement provides expanded indications for cardiac resynchronization therapy (CRT) in an effort to clarify which patients are most likely to benefit from CRT. Additional updates include guidance regarding the frequency of in-person and remote monitoring of patients with cardiovascular implantable electronic devices. 

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay supersedes the pacemaker recommendations made in this 2012 Focused Update and 2008 guidelines.

2012 HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection

Device Therapy

June 26, 2012—The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the 2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. The statement provides a state-of-the-art review of the field and reports consensus recommendations on pacemaker device and mode selection. It is a guide to facilitate the appropriate use of single vs. dual-chamber devices for patients who already meet guidelines for pacemaker implantation.

This document was reaffirmed on November 18, 2020, and will be formally assessed by November 2025.

2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern


May 10, 2012—The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a Wolff-Parkinson-White (WPW) electrocardiographic pattern. This is also the first collaboration between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design

Atrial Fibrillation

March 5, 2012—The purpose of this expert consensus statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation. It reports on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.

 This document has been retired and replaced by 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.

Full Report from the First Annual Heart Rhythm Society Research Forum: A Vision for Our Research Future, “Dream, Discover, Develop, Deliver”


November 10, 2011—The Heart Rhythm Society organized a research forum held on December 14–15, 2010, to develop a vision for future arrhythmia research and to design practical approaches to ensure these visions are realized. The goal of the present communication is to summarize the discussions and recommendations of this research forum.

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

HRS Endorsed / Affirmed

November 8, 2011—The impetus for the guidelines is based on an appreciation of the frequency of this clinical entity and a realization that many aspects of clinical management, including the use of diagnostic modalities, genetic testing, utilization of implantable cardioverter defibrillators, and therapies for refractory symptoms lack consensus. The discussion and recommendations about the various diagnostic modalities apply to patients with established hypertrophic cardiomyopathy and to a variable extent to patients with a high index of suspicion of the disease.